SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001104659-23-108344
Filing Date
2023-10-10
Accepted
2023-10-10 17:01:00
Documents
2
Group Members
SANGWOO PARK

Document Format Files

Seq Description Document Type Size
1 SC 13D tm238160d1_sc13d.htm SC 13D 68008
2 EXHIBIT 1 tm238160d1_ex-1.htm EX-99.1 5639
  Complete submission text file 0001104659-23-108344.txt   75280
Mailing Address 3001 DAIMLER ST, SANTA ANA CA 92705
Business Address 3001 DAIMLER ST, SANTA ANA CA 92705 (949) 396-6830
NKGen Biotech, Inc. (Subject) CIK: 0001845459 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-92576 | Film No.: 231318639
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O NKGEN BIOTECH, INC. 3001 DAIMLER STREET SANTA ANA CA 92705
Business Address C/O NKGEN BIOTECH, INC. 3001 DAIMLER STREET SANTA ANA CA 92705 949-396-6830
NKMAX Co., Ltd. (Filed by) CIK: 0001996481 (see all company filings)

IRS No.: 000000000 | State of Incorp.: M5 | Fiscal Year End: 1231
Type: SC 13D